Pricing Log in Create free account

Milestone Scientific, Inc. (MLSS) vs Nephros Inc. (NEPH)

Milestone Scientific, Inc. and Nephros Inc. are both Medical Instruments & Supplies companies. Nephros Inc. is the larger, with a market value of $33.6M against $27.1M — 1.2× the size. Milestone Scientific, Inc. has negative trailing earnings, so its P/E is not meaningful; Nephros Inc. trades at 18.0×. Nephros Inc. grew revenue faster over the last twelve months: 20.4% against 3.72%. Nephros Inc. has the higher net margin (8.86% vs −44.0%) and the higher return on invested capital (14.3% vs −136.2%). Across the 18 metrics below, Nephros Inc. leads on 17 and Milestone Scientific, Inc. on 1.

Valuation

Metric MLSS NEPH Medical Instruments & Supplies median
P/E n/m 17.98 30.28
P/S 2.97 1.59 2.49
P/B 8.05 2.74 2.34
Price to free cash flow n/m n/m 23.49
EV/EBITDA n/m 15.32 14.87
EV/Sales 2.80 1.38 2.75
Earnings yield (14.67%) 5.56% 0.00%
Free cash flow yield (3.06%) (3.02%) 0.59%

Profitability

Metric MLSS NEPH Medical Instruments & Supplies median
Gross margin 70.23% 60.55% 53.60%
Operating margin (43.56%) 8.48% 1.97%
Net margin (43.98%) 8.86% 0.00%
Free cash flow margin (6.98%) (4.22%) 2.36%
Return on equity (121.68%) 16.95% 0.00%
Return on assets (50.54%) 13.39% 0.00%
Return on invested capital (136.16%) 14.29% 0.13%

Growth

Metric MLSS NEPH Medical Instruments & Supplies median
Revenue growth (TTM) 3.72% 20.36% 8.97%
EPS growth (last fiscal year) (16.67%) 1,471.43% 6.51%
Revenue growth, 5-year CAGR 10.54% 17.02% 8.85%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MLSS NEPH Medical Instruments & Supplies median
Debt to equity 0.14 0.00 0.10
Current ratio 1.85 5.50 2.47
Net debt to EBITDA 0.05 (4.20) 0.97

Dividend

Metric MLSS NEPH Medical Instruments & Supplies median
Dividend yield — — 1.02%
Payout ratio — — 0.27

Size

Metric MLSS NEPH Medical Instruments & Supplies median
Market cap 27.11m 33.59m 1.71b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack